About the Company
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GLYC News
GlycoMimetics Inc hosts conference call for investors
The company, GlycoMimetics Inc, is set to host investors and clients on a conference call on 3/27/2024 8:59:30 AM. The call comes after the ...
Positive Signs As Multiple Insiders Buy GlycoMimetics Stock
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in ...
GlycoMimetics Inc GLYC
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
GlycoMimetics, Inc. (GKO.F)
ROCKVILLE, Md., February 12, 2024--GlycoMimetics, Inc. (the "Company") (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on ...
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on ...
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference
ROCKVILLE, Md., February 26, 2024--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Harout Semerjian, ...
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
ROCKVILLE, Md.--(BUSINESS WIRE)-- GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on ...
GlycoMimetics Inc
Picking the best bond ETF can be hard with so many options available. Here's what the experts suggest focusing on.
GlycoMimetics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
GlycoMimetics Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...